NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma
NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma
Recruiting · NCT07114367 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-01-30 | NCT07114367 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NOBO Medicine | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Catholic univ of Yeouido St Mary's Hospital | Seoul | South Korea | 2 |
| Chonnam National University Hwasun Hospital | Hwasun | South Korea | 12 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Bundang Hospital | Seongnam | South Korea | 42 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Ulsan University Hospital | Ulsan | South Korea | 37 |